Privacy First Marketing: An Industry POV
Thought Leaders Weigh In on The Future of Privacy First Marketing
Presented by
The DHC Group and Members
ACTIONABLE INSIGHTS
The Future of Privacy First Marketing
The shift away from (browser-based) cookies by Apple, Firefox, and Google has ushered in a new era of targeting and audience metrics for brands, marketers, and agencies. This shift will have an acute impact on the approach pharma companies will have to take to successfully promote their products online.
The DHC Group and its members will be affected by these privacy-first changes – so we turned to our membership to gain a better understanding of some of the challenges and opportunities facing pharma brand marketers. The DHC Group interviewed more than 20 leading digital marketing experts from ad tech, data firms, agencies, publishers, and pharmaceutical organizations and asked them how they plan to adapt to the “privacy-first” era – and what’s ahead for audience targeting, tracking, and metrics.
This Soon-To-Be-Released POV for Pharma Marketers will offer thought leader insights on to help marketers map out a privacy first strategy. Here’s a sample of what will be covered in the POV:
- How do you plan to target messaging and advertising in the post cookie era?
- What do you think customer targeting and the user experience will look like in 2030?
- How should brands think about their agency and marketing partners and future investments?
- Is there a future for scalable first-party data across the industry and what does that look like?
- Will contextual targeting become more important given all of these new privacy restrictions?
